tag abbvie 
pharmaphorum
JANUARY 5, 2022
The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. The post FDA gives AbbVie’s c-Met lung cancer ADC a breakthrough tag appeared first on.
Pharmaceutical Technology
FEBRUARY 22, 2023
But Amgen received support from other players, including AbbVie, at the start of the year. Both drugs come with a high price tag. Not even two weeks ago, the likes of AstraZeneca and Pfizer voiced their support of Sanofi’s side through amicus briefs submitted to the Court.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 25, 2022
The category is getting increasingly crowed, with Pfizer also anticipating approval of its BCMA-targeting bispecific elranatamab in the coming months, with several more multiple myeloma bispecifics coming through the pipeline from the likes of Regeneron, AbbVie, Amgen and Roche.
Pharmaceutical Technology
MAY 15, 2023
Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.
pharmaphorum
JANUARY 21, 2022
This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.
The Pharma Data
MAY 5, 2021
AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). . Startup sets out to tackle the gene therapy manufacturing crisis ( Endpoints ). Esker, a new biotech startup, launches with plans to make targeted immune drugs ( BioPharma Dive ).
XTalks
MARCH 22, 2023
And in 2020, AbbVie bought out Allergan for $63 billion, four years after Allergan and Pfizer abandoned their planned megamerger after a years-long will-they-or-won’t-they courtship. In addition, nearly half of all new drugs launched between 2020 and 2021 came with a price tag of $150,000 per year, or more.
Expert insights. Personalized for you.
110 
Let's personalize your content